.svg){kind=small}
Driving innovation
in clinical research
.png)
At the forefront of drug evolution
Leading the way in First-in-Human studies with a variety of patient populations.
Take your asset from First-in-Human to Proof of Concept in under one year with our specialist services.
Take your asset from First-in-Human to Proof of Concept in under one year with our specialist services.
Thorough QT Studies
.svg)
Take your asset from FIH to POC in under one year using our specialist services.
-min.jpg)
We are Richmond Pharmacology.
We are committed to advancing science and driving innovations in drug development.
We reduce drug development timelines using knowledge and expertise accumulated from over 500 clinical trials.
We reduce drug development timelines using knowledge and expertise accumulated from over 500 clinical trials.
Centre of excellence.
Richmond Pharmacology is a centre for excellence for First-In-Human and early phase clinical studies. We reduce drug development timelines using our Adaptive Protocols and efficient Patient Recruitment.
Our sponsors are granted fast international marketing approvals due to our inclusive study design which fulfils the data requirements of global regulators.
Our sponsors are granted fast international marketing approvals due to our inclusive study design which fulfils the data requirements of global regulators.
Work with us
We work with leading genetic engineering organisations, top 10 pharma companies and dynamic biotechs to assess the safety and efficacy of new therapeutics.
By working with us, you will gain a research partner who can expedite your study start up, enable fast decisions and reduce your drug development timelines.
-min.jpg)
.jpg)
Latest news
Engaging Hearts and Hands: A Day of Volunteering at Arc Nursery
September 12, 2023
Discover how Richmond's dedicated team of volunteers is making a positive impact on young minds at Arc Nursery
Read moreExciting Research Update: Enhancing Blinding in Clinical Trials with Auto-Injectors
September 5, 2023
We’re excited to share the findings of our recent study on the use of auto-injector systems (A-INJ) in randomized controlled trials (RCTs) by Dr Jorg Taubel, Dr Ulrike Lorch, Dr Thomas York and Vishal Aggarwal.
Read moreEvents
BioJapan 2023
11-13 October 2023
BioJapan is "Asia's largest partnering event consisting of Exhibition, Seminar, and Partnering program".
View event
